Volume Versus Concentration: Clinical Effectiveness of Single Shot Quadrates Lumborum Block Using Either a High Volume/Low Concentration or Low Volume/High Concentration Injectate for Total Hip Arthroplasty.
Source: ClinicalTrials.gov NCT04259645 ↗No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Consumption of Opioids During the First 24 Hours After Surgery. |
46.2; 35.0 | — |
| PRIMARY Pain Measurement Through VAS (Visual Analogue Score) at Rest |
4.78; 5.50 | — |
| SECONDARY Time to 100ft Ambulation After Surgery |
1534; 1178 | — |
| SECONDARY Time to Consumption of the First Opioid After Surgery. |
120; 165 | — |
| SECONDARY Time to Hospital Discharge |
1865; 1560 | — |
Eligibility Criteria
Inclusion Criteria
Patients 18-80 years old Patients undergoing total hip arthroplasty BMI 19-45, >50 kg Male and Female All races American Society of Anesthesiologists physical status classification I, II, III Spinal Anesthesia Provided
Exclusion Criteria
Pregnancy Non english speaking or inability to participate in the study Patients with coagulopathy or With INR >1.5 the day of the surgery. pharmacologic coagulopathy: patients on xarelto, plavix, or any kind of "Blood Thinners" Chronic steroid use: patients with consumption of steroid for more than 3 months.
Chronic pain: pain for more than 3 months Chronic opiate use : consumption of opioids for more than 3 months.
Data sourced from ClinicalTrials.gov (NCT04259645). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.